Inhaled NO reduces leukocyte-endothelial cell interactions and myocardial dysfunction in endotoxemic rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 6 47-6, 2000, Pages

  Nevière, Rémi ^a   Guery, Benoit ^a   Mordon, Serge ^a   Zerimech, Farid ^a   Charré, Stéphane ^a   Wattel, Francis ^a   Chopin, Claude ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Endotoxin; Left ventricular function; Microcirculation; Nitric oxide inhalation

Indexed keywords

ENDOTOXIN; FLUORESCEIN ISOTHIOCYANATE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTOXEMIA; FLUORESCENCE; HEART FAILURE; INFLAMMATION; INHALATION; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MESENTERIC VEIN; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VENULE;

EID: 0033933496     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.6.h1783     Document Type: Article

References (43)

1. Brown JM, Grosso MA, Terada LS, Whitman G, Banerjee A, White CW, Harken AH, and Repine JE. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Natl Acad Sci USA 86: 2516-2520, 1989.
2. Clancy RM, Leszczynska-Piziak J, and Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90: 1116-1121, 1992.
3. Cobb JP and Danner RL. Nitric oxide and septic shock. JAMA 275: 1192-1196, 1996.
4. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MAJ, Shin WS, and Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96: 60-68, 1995.
5. Dhainaut J-F, Huyghebaert M-F, Monsallier JF, Lefevre G, Ava-Santucci JD, Brunet F, Villemant D, Carli A, and Raichvarg D. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 75: 533-541, 1987.
6. Entman ML, Youker K, Shoji T, Kukielka G, Shappell SB, Taylor AA, and Smith CW. Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/ CD18-ICAM-1 adherence. J Clin Invest 90: 1335-1345, 1992.
7. Flesch M, Kilter H, Cremer B, Laufs U, Sudkamp M, Ortmann M, Muller FU, and Bohm M. Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite. J Am Coll Cardiol 33: 1062-1070, 1999.
8. Fox-Robichaud A, Payne D, Hasan SU, Ostrovsky L, Fairhead T, Reinhardt P, and Kubes P. Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest 101: 2497-2505, 1998.
9. Gaboury J, Woodman RC, Granger DN, Reinhardt P, and Kubes P. Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol Heart Circ Physiol 265: H862-H867, 1993.
10. Goddard CM, Allard MF, Hogg JC, Herbertson MJ, and Walley KR. Myocardial morphometric changes related to decreased contractility after endotoxin. Am J Physiol Heart Circ Physiol 270: H1446-H1452, 1996.
11. Granger DN and Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 55: 662-675, 1994.
12. Granton JT, Goddard CM, Allard MF, Van Eeden SF, and Walley KR. Leukocytes and decreased left-ventricular contractility during endotoxemia in rabbits. Am J Respir Crit Care Med 155: 1977-1983, 1997.
13. Gries A, Bode C, Karlheinz P, Herr A, Bohrer H, Motsch J, and Martin E. Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. Circulation 97: 1481-1487, 1998.
14. Gries A, Bottiger BW, Dorsam J, Bauer H, Weimann J, Bode C, Martin E, and Motsch J. Inhaled nitric oxide inhibits platelet aggregation after pulmonary embolism in pigs. Anesthesiology 86: 387-393, 1997.
15. Grocott-Mason R, Fort S, Lewis MJ, and Shah AM. Myocardial relaxant effect of exogenous nitric oxide in isolated ejecting hearts. Am J Physiol Heart Circ Physiol 266: H1699-H1705, 1994.
16. Guery B, Nevière R, Viget N, Foucher C, Fialdes P, Wattel F, and Beaucaire G. Inhaled nitric oxide preadministration modulates local and remote ischemia-reperfusion organ injury in a rat model. J Appl Physiol 87: 47-53, 1999.
17. Iigo Y, Suematsu M, Higashida T, Oheda JI, Matsumoto K, Wakabayashi Y, Ishimura Y, Miyasaka M, and Takashi T. Constitutive expression of ICAM-1 in rat microvascular systems analyzed by laser confocal microscopy. Am J Physiol Heart Circ Physiol 273: H138-H147, 1997.
18. Keaney, JF Jr, Simon DI, Stamler JS, Jaraki O, Scharfstein J, Vita JA, and Loscalzo J. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest 91: 1582-1589, 1993.
19. Kelm M and Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res 66: 1561-1575, 1990.
20. Kubes P and Granger DN. Nitric oxide modulates microvascular permeability in the feline small intestine. Am J Physiol Heart Circ Physiol 262: H611-H615, 1992.
21. Kubes P, Kanwar S, Niu X-F, and Gaboury J. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 7: 1293-1299, 1993.
22. Kubes P, Kurose I, and Granger DN. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am J Physiol Heart Circ Physiol 267: H931-H937, 1994.
23. Kubes P, Suzuki M, and Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651-4655, 1991.
24. Lam C, Tyml K, Martin CM, and Sibbald WJ. The skeletal muscle microcirculation in a rat model of normotensive sepsis. J Clin Invest 94: 2077-2083, 1994.
25. Lefer DJ, Flynn DM, Anderson DC, and Buda AJ. Combined inhibition of P-selectin and ICAM-1 reduces myocardial injury following ischemia and reperfusion. Am J Physiol Heart Circ Physiol 271: H2421-H2429, 1996.
26. Ma XL, Weyrich AS, Lefer DJ, and Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 72: 403-412, 1993.
27. McDonough KH, Henry JJ, Lang CH, and Spitzer JJ. Substrate utilization and high energy phosphate levels of hearts from hyperdynamic septic rats. Circ Shock 18: 161-170, 1986.
28. McKechnie K, Furman BL, and Parratt JR. Modification by oxygen free radical scavengers of the metabolic and cardiovascular effects of endotoxin infusion in conscious rats. Circ Shock 19: 429-439, 1986.
29. Natanson C, Danner RL, Elin RJ, Hosseini JM, Peart KW, Banks SM, MacVittie TJ, Walker RI, and Parillo JE. Role of endotoxemia in cardiovascular dysfunction and mortality. J Clin Invest 83: 243-251, 1989.
30. Natanson C, Fink MP, Ballantyne HK, MacVittie TJ, Conklin JJ, and Parillo JE. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest 78: 259-270, 1986.
31. Osborne DL, Aw TY, Cepinska G, and Kvietys PR. Development of ischemia/reperfusion tolerance in the rat small intestine. An epithelium-independent event. J Clin Invest 94: 1910-1918, 1994.
32. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, and Parillo JE. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100: 483-490, 1984.
33. Perry MA and Granger DN. Role of CD11/CD18 in shear rate dependent leukocyte-endothelial cell interactions in cat mesenteric venules. J Clin Invest 87: 1798-1804, 1991.
34. Poon BY, Goddard CM, Leaf CD, Russel JA, and Walley KR. L-2-Oxothiazolidine-4-carboxylic acid prevents endotoxin-induced cardiac dysfunction. Am J Respir Crit Care Med 158: 1109-1113, 1998.
35. Quezado ZM, Natanson C, Karzai W, Danner RL, Koev CA, Fitz Y, Dolan DP, Richmond S, Wilson SM, and Eichacker PQ. Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. coli pneumonia and sepsis. J Appl Physiol 84: 107-115, 1998.
36. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, and Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328: 399-405, 1993.
37. Singh S and Evans TW. Nitric oxide, the biological mediator of the decade: fact or fiction? Eur Respir J 10: 699-707, 1997.
38. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, and Piandatosi CA. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 276: 2034-2037, 1997.
39. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, and Loscalzo J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 89: 444-448, 1992.
40. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, and Parrillo JE. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321: 280-287, 1989.
41. Wang P, Ba ZF, and Chaudry IH. Nitric oxide. To block or enhance its production during sepsis? Arch Surg 129: 1137-1142, 1994.
42. Wang P, Ba ZF, and Chaudry IH. Endothelium-dependent relaxation is depressed at the macro- and microcirculatory levels during sepsis. Am J Physiol Regulatory Integrative Comp Physiol 269: R988-R994, 1995.
43. Zhou M, Wang P, and Chaudry IH. Endothelial nitric oxide synthase is downregulated during hyperdynamic sepsis. Biochim Biophys Acta 1335: 182-190, 1997.